Your prediction
Matthews International Corp. Stock
The Matthews International Corp. price is unchanged compared to yesterday.
Pros and Cons of Matthews International Corp. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Matthews International Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Matthews International Corp. | 0.000% | -3.448% | -7.438% | 21.938% | -0.444% | -40.426% | -29.114% |
| Vuzix Corp. | -2.320% | -12.636% | 44.490% | 27.155% | 18.474% | -24.407% | -77.293% |
| USANA Health Sciences Inc. | 2.070% | -1.290% | -2.548% | -40.234% | -7.273% | -74.068% | -82.105% |
| Pola Orbis Holdings Inc. | 0.000% | 0.758% | -1.481% | -18.405% | -4.317% | -47.638% | -68.632% |
Comments
Matthews International Co. (NASDAQ: MATW) had its price target lowered by analysts at B. Riley from $54.00 to $40.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MATW provided by MarketBeat
Matthews International Co. (NASDAQ: MATW) had its price target lowered by analysts at B. Riley from $61.00 to $59.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MATW provided by MarketBeat
Matthews International Co. (NASDAQ: MATW) had its price target raised by analysts at B. Riley from $50.00 to $64.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MATW provided by MarketBeat
News
Eton Pharmaceuticals Q1 Earnings Call Highlights
Eton Pharmaceuticals (NASDAQ:ETON) raised its 2026 revenue outlook after reporting record first-quarter product sales and highlighting early progress from two recent product launches, DESMODA and
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance
Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million?
According to its SEC filing dated May 4, 2026, Matthews International Capital Management LLC purchased 242,785 additional shares of Yum China (NYSE:YUMC) in the first quarter.
The estimated value of
